SOMERSET, N.J. (PRWEB)
April 19, 2022

Catalent, the global leader in enabling biopharma, cell, gene and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple modalities, today announced that Patrick Murphy, Director of Continuous Improvement, Technology and Engineering at Catalent’s Philadelphia facility, will be co-hosting a workshop at the upcoming Global Clinical Supplies Group (GCSG) 2022 Annual U.S. Conference, which is to be held at the Hyatt Hill Country Resort & Spa, San Antonio, Texas, from May 1-4, 2022.

The workshop, entitled “Using Value Stream Mapping to Improve Clinical Supply Chain Efficiency”, will take place on May 3 at 1:45 p.m. CDT, and again on the following day at 1 p.m. The session will focus on how clinical supply chains can utilize value stream mapping, which is a lean management method that allows a product delivery process to be visualized, analyzed and improved.

Also at the event, Michael McNear, Catalent’s Director of Operations at its San Diego clinical supply facility, will participate in a panel session entitled, “Clinical Trial Supplies: Creating (& Keeping) the Workforce of the Future”. The session, at 3 p.m. CDT on May 3, will see industry experts discuss current recruitment methods, and how the practice needs to adapt to hire and keep talent in order to maintain organizations’ needs to accomplish current and future goals.

With a network spanning the U.S., U.K., Germany, Singapore, Japan, and China, plus more than 50 additional global depots, Catalent’s clinical supply services can handle a broad range of international compliance and distribution requirements to support global clinical trials.

To find out more information about the event, visit https://www.clinical.catalent.com/events/gcsg-2022-us-annual-conference/.

About Catalent Clinical Supply Services

Catalent solves today’s clinical trial challenges and develops innovative solutions for the future. The company’s commitment to quality and service excellence is evident in its flexible solutions, modern global facilities, and over 25 years’ experience of reliably supplying thousands of studies of all sizes and complexities, all around the world.

About Catalent

Catalent is the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world.

With broad and deep scale and expertise in development sciences, delivery technologies, and multi-modality manufacturing, Catalent is a preferred industry partner for personalized medicines, consumer health brand extensions, and blockbuster drugs. Catalent helps accelerate over 1,000 partner programs and launch over 150 new products every year. Its flexible manufacturing platforms at over 50 global sites supply over 70 billion doses of more than 7,000 products to over 1,000 customers annually.

Catalent’s expert workforce exceeds 18,000, including more than 2,500 scientists and technicians. Headquartered in Somerset, New Jersey, the company generated $4 billion in revenue in its 2021 fiscal year. For more information, visit http://www.catalent.com.

More products. Better treatments. Reliably supplied.™

Share article on social media or email: